Skip to Main Content

Author Details

Eric Hunter
Center for Family Health Research Zambia
1971
323
71
Sarah J Ratcliffe (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36851349Cohort-Specific Peptide Reagents Broaden Depth and Breadth Estimates of the CD8 T Cell Response to HIV-1 Gag Potential T Cell Epitopes.Vaccines (Basel)2023
37553348Intradermal but not intramuscular modified vaccinia Ankara immunizations protect against intravaginal tier2 simian-human immunodeficiency virus challenges in female macaques.Nat Commun2023
36851349Cohort-Specific Peptide Reagents Broaden Depth and Breadth Estimates of the CD8 T Cell Response to HIV-1 Gag Potential T Cell Epitopes.Vaccines (Basel)2023
37553348Intradermal but not intramuscular modified vaccinia Ankara immunizations protect against intravaginal tier2 simian-human immunodeficiency virus challenges in female macaques.Nat Commun2023
35215928Characterization of Near Full-Length Transmitted/Founder HIV-1 Subtype D and A/D Recombinant Genomes in a Heterosexual Ugandan Population (2006-2011).Viruses2022
36532063Assessment of a diverse panel of transmitted/founder HIV-1 infectious molecular clones in a luciferase based CD8 T-cell mediated viral inhibition assay.Front Immunol2022
35215928Characterization of Near Full-Length Transmitted/Founder HIV-1 Subtype D and A/D Recombinant Genomes in a Heterosexual Ugandan Population (2006-2011).Viruses2022
36532063Assessment of a diverse panel of transmitted/founder HIV-1 infectious molecular clones in a luciferase based CD8 T-cell mediated viral inhibition assay.Front Immunol2022
32879950Cohort Profile: IAVI's HIV epidemiology and early infection cohort studies in Africa to support vaccine discovery.Int J Epidemiol2021
33588436A Stronger Innate Immune Response During Hyperacute Human Immunodeficiency Virus Type 1 (HIV-1) Infection Is Associated With Acute Retroviral Syndrome.Clin Infect Dis2021
33529681Comprehensive epitope mapping using polyclonally expanded human CD8 T cells and a two-step ELISpot assay for testing large peptide libraries.J Immunol Methods2021
34275199Selective HLA restriction enables the evaluation and interpretation of immunogenic breadth at comparable levels to that observed with broader HLA distribution.Proteomics2021
34275180Direct identification of HLA-presented CD8 T cell epitopes from transmitted founder HIV-1 variants.Proteomics2021
33846309Human anogenital monocyte-derived dendritic cells and langerin+cDC2 are major HIV target cells.Nat Commun2021
33731158Elevated levels of inflammatory plasma biomarkers are associated with risk of HIV infection.Retrovirology2021
33777023A Novel Sample Selection Approach to Aid the Identification of Factors That Correlate With the Control of HIV-1 Infection.Front Immunol2021
33560366Genital Abnormalities, Hormonal Contraception, and Human Immunodeficiency Virus Transmission Risk in Rwandan Serodifferent Couples.J Infect Dis2021
33872331Plasmacytoid dendritic cells have divergent effects on HIV infection of initial target cells and induce a pro-retention phenotype.PLoS Pathog2021
33556148The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infection.PLoS Pathog2021
33498793HIV-1 <i>Gag-Pol</i> Sequences from Ugandan Early Infections Reveal Sequence Variants Associated with Elevated Replication Capacity.Viruses2021
33710015HLA-associated preadaptation in HIV Vif is associated with higher set point viral load and faster CD4+ decline in Zambian transmission pairs.AIDS2021
32879950Cohort Profile: IAVI's HIV epidemiology and early infection cohort studies in Africa to support vaccine discovery.Int J Epidemiol2021
33433171Antiretroviral Therapy Use and HIV Transmission Among Discordant Couples in Nonresearch Settings in Kigali, Rwanda.Sex Transm Dis2021
34788349Breadth of CD8 T-cell mediated inhibition of replication of diverse HIV-1 transmitted-founder isolates correlates with the breadth of recognition within a comprehensive HIV-1 Gag, Nef, Env and Pol potential T-cell epitope (PTE) peptide set.PLoS One2021
34489909Proviral Turnover During Untreated HIV Infection Is Dynamic and Variable Between Hosts, Impacting Reservoir Composition on ART.Front Microbiol2021
34690973Increased Frequency of Inter-Subtype HIV-1 Recombinants Identified by Near Full-Length Virus Sequencing in Rwandan Acute Transmission Cohorts.Front Microbiol2021
33872331Plasmacytoid dendritic cells have divergent effects on HIV infection of initial target cells and induce a pro-retention phenotype.PLoS Pathog2021
33846309Human anogenital monocyte-derived dendritic cells and langerin+cDC2 are major HIV target cells.Nat Commun2021
33710015HLA-associated preadaptation in HIV Vif is associated with higher set point viral load and faster CD4+ decline in Zambian transmission pairs.AIDS2021
33731158Elevated levels of inflammatory plasma biomarkers are associated with risk of HIV infection.Retrovirology2021
33588436A Stronger Innate Immune Response During Hyperacute Human Immunodeficiency Virus Type 1 (HIV-1) Infection Is Associated With Acute Retroviral Syndrome.Clin Infect Dis2021
33560366Genital Abnormalities, Hormonal Contraception, and Human Immunodeficiency Virus Transmission Risk in Rwandan Serodifferent Couples.J Infect Dis2021
33529681Comprehensive epitope mapping using polyclonally expanded human CD8 T cells and a two-step ELISpot assay for testing large peptide libraries.J Immunol Methods2021
33556148The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infection.PLoS Pathog2021
33777023A Novel Sample Selection Approach to Aid the Identification of Factors That Correlate With the Control of HIV-1 Infection.Front Immunol2021
33498793HIV-1 <i>Gag-Pol</i> Sequences from Ugandan Early Infections Reveal Sequence Variants Associated with Elevated Replication Capacity.Viruses2021
34788349Breadth of CD8 T-cell mediated inhibition of replication of diverse HIV-1 transmitted-founder isolates correlates with the breadth of recognition within a comprehensive HIV-1 Gag, Nef, Env and Pol potential T-cell epitope (PTE) peptide set.PLoS One2021
34489909Proviral Turnover During Untreated HIV Infection Is Dynamic and Variable Between Hosts, Impacting Reservoir Composition on ART.Front Microbiol2021
34690973Increased Frequency of Inter-Subtype HIV-1 Recombinants Identified by Near Full-Length Virus Sequencing in Rwandan Acute Transmission Cohorts.Front Microbiol2021
34275199Selective HLA restriction enables the evaluation and interpretation of immunogenic breadth at comparable levels to that observed with broader HLA distribution.Proteomics2021
34275180Direct identification of HLA-presented CD8 T cell epitopes from transmitted founder HIV-1 variants.Proteomics2021
33433171Antiretroviral Therapy Use and HIV Transmission Among Discordant Couples in Nonresearch Settings in Kigali, Rwanda.Sex Transm Dis2021
32393800T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers.Nat Med2020
32376625Differential Vpu-Mediated CD4 and Tetherin Downregulation Functions among Major HIV-1 Group M Subtypes.J Virol2020
32126947Sociodemographic factors and STIs associated with <i>Chlamydia trachomatis</i> and <i>Neisseria gonorrhoeae</i> infections in Zambian female sex workers and single mothers.Int J STD AIDS2020
32393800T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers.Nat Med2020
32461316Better Viral Control despite Higher CD4[+] T Cell Activation during Acute HIV-1 Infection in Zambian Women Is Linked to the Sex Hormone Estradiol.J Virol2020
32492044HIV-1 variants are archived throughout infection and persist in the reservoir.PLoS Pathog2020
32886726Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection.PLoS Pathog2020
32602618Cost-effectiveness of couples' voluntary HIV counselling and testing in six African countries: a modelling study guided by an HIV prevention cascade framework.J Int AIDS Soc2020
  • 1 - 50 of 646

Recommended Authors

Rush University Medical Center
Career Start Year 2011
Number of shared co-authors 0
Institut Pasteur, CNRS UMR 3569
Career Start Year 2009
Number of shared co-authors 3
The Institute of Medical Science, The University of Tokyo
Career Start Year 2008
Number of shared co-authors 1
Gladstone Institutes
Career Start Year 2007
Number of shared co-authors 0
University of California
Career Start Year 2006
Number of shared co-authors 1
University of California
Career Start Year 2005
Number of shared co-authors 2
Albert Einstein College of Medicine
Career Start Year 2002
Number of shared co-authors 0
Washington State University
Career Start Year 2000
Number of shared co-authors 0
Icahn School of Medicine at Mount Sinai
Career Start Year 1997
Number of shared co-authors 5
Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 6
The Rockefeller University
Career Start Year 1995
Number of shared co-authors 4
University College London
Career Start Year 1995
Number of shared co-authors 3
Icahn School of Medicine at Mount Sinai
Career Start Year 1993
Number of shared co-authors 2
Institute of Virology, Philipps University Marburg
Career Start Year 1992
Number of shared co-authors 1
University of Utah
Career Start Year 1991
Number of shared co-authors 2
Altius Institute for Biomedical Sciences
Career Start Year 1990
Number of shared co-authors 4
Institute of Virology, Medical Center - University of Freiburg
Career Start Year 1989
Number of shared co-authors 0
Instituto de Investigacion Hospital 12 de Octubre (imas12)
Career Start Year 1988
Number of shared co-authors 1
Institut Pasteur, Universite Paris Cite, CNRS UMR9
Career Start Year 1987
Number of shared co-authors 5
University of Massachusetts Chan Medical School
Career Start Year 1985
Number of shared co-authors 1
Ben-Gurion University of the Negev
Career Start Year 1984
Number of shared co-authors 1
Max-von-Pettenkofer Institute, Ludwig-Maximilians-University (LMU) Munich
Career Start Year 1983
Number of shared co-authors 0
Rockefeller University
Career Start Year 1981
Number of shared co-authors 7
University of California san francisco
Career Start Year 1981
Number of shared co-authors 3
Carver College of Medicine, University of Iowa
Career Start Year 1978
Number of shared co-authors 0
University of California San Diego, USA VA San Diego Healthcare System
Career Start Year 1978
Number of shared co-authors 3
Frederick National Laboratory
Career Start Year 1977
Number of shared co-authors 16
Tulane University School of Medicine
Career Start Year 1974
Number of shared co-authors 1
Columbia University
Career Start Year 1973
Number of shared co-authors 3
University of Texas San Antonio
Career Start Year 1971
Number of shared co-authors 2

Collaborators

Emory University
Co-authored papers 86
University of Washington
Co-authored papers 44
Rollins School of Public Health, Emory University
Co-authored papers 35
Co-authored papers 21
University of Alabama at Birmingham
Co-authored papers 21
Co-authored papers 19
Co-authored papers 13
Co-authored papers 13
Co-authored papers 10
Co-authored papers 9
Co-authored papers 8
Co-authored papers 8
Co-authored papers 8
Ragon Institute of Mass General
Co-authored papers 8
Co-authored papers 8
Co-authored papers 7
Co-authored papers 7
Institute for Immunity, Stanford University School of Medicine, Stanford University
Co-authored papers 7
Co-authored papers 6
Co-authored papers 6
Co-authored papers 5
Co-authored papers 5
Co-authored papers 5
Co-authored papers 4
University of Alabama at Birmingham
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4